IKS Health reported strong Q2 FY26 results with PBT up 58.5%, EBITDA rising 43%, and margins improving significantly year-over-year.
Trump Tariff Delay Boosts Markets
Tesla Spain Sales Decline as EV Market Booms
India Extends Cotton Duty-Free Import
India Eyes Equities Market Growth
Bondada's Rs 836 Crore BESS Project Boosts Tamil Nadu Renewables
TCC Concept Acquires Pepperfry
RBI: India's Economy Strong & On Track
News that matters the most ⚡